Tarsus Pharmaceuticals, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Tarsus Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2020 to Q3 2024.
  • Tarsus Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 38.4M shares, a 25.3% increase year-over-year.
  • Tarsus Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 29.4M shares, a 19.3% increase from 2022.
  • Tarsus Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 24.6M shares, a 19.8% increase from 2021.
  • Tarsus Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 20.6M shares, a 231% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 38.4M +7.76M +25.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 37.8M +11M +41% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 35.3M +8.56M +32% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 29.4M +4.76M +19.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 30.6M +3.96M +14.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 26.8M +2.48M +10.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 26.7M +6.03M +29.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 24.6M +4.07M +19.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 26.7M +6.02M +29.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 24.3M +3.78M +18.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 20.7M +374K +1.84% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 20.6M +14.3M +231% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-17
Q3 2021 20.6M +17.9M +656% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 20.6M +17.9M +675% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 20.3M +17.7M +667% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 6.21M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-14
Q3 2020 2.73M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 2.65M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 2.65M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.